Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis
|
|
- Amanda Lamb
- 6 years ago
- Views:
Transcription
1 REVIEW /j x Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis W. Sougakoff National Reference Centre for Mycobacteria (CNR-MyRMA), Laboratoire de Bactériologie-Hygiène, UPMC, ER5, Faculté de Médecine Pitié-Salpêtrière, Paris, France Abstract Genotyping of Mycobacterium tuberculosis has been extensively used for investigating epidemics of multidrug-resistant strains of M. tuberculosis, in order to identify the factors involved in the transmission of such strains and determine effective control programmes to limit their expansion at both the individual and population levels. Here, we review the methods currently used to study the molecular epidemiology of multidrug-resistant M. tuberculosis strains, and the insights provided by these techniques regarding global trends and the transmission dynamics of multidrug-resistant tuberculosis at a world scale. Keywords: Molecular epidemiology, multidrug-resistant, Mycobacterium, resistance, tuberculosis Article published online: 7 May 2011 Clin Microbiol Infect 2011; 17: Corresponding author: W. Sougakoff, Laboratoire de Bactériologie-Hygiène, UPMC ER5, Faculté de Médecine Pitié-Salpêtrière, 91 boulevard de l Hôpital, Paris Cedex 13, France wladimir.sougakoff@upmc.fr Introduction Multidrug resistance, i.e. resistance to at least rifampin and isoniazid, in Mycobacterium tuberculosis is caused by the sequential accumulation of mutations in the genes encoding the targets of rifampin and isoniazid. Extensively drug-resistant (XDR) tuberculosis (TB) is defined as multidrug resistance (resistance to isoniazid and rifampin), plus resistance to a fluoroquinolone and any of the injectable second-line drugs (amikacin, capreomycin, or kanamycin). The emergence and spread of multidrug-resistant (MDR) and XDR TB is hampering efforts to control and manage TB. Since the emergence of MDR strains in the 1990s, the prevalence of MDR TB has slowly but constantly increased, such that it now accounts for approximately 5% of global TB cases. According to the Multidrug and extensively drug-resistant TB 2010 Global report on surveillance and response, it can be estimated that cases of MDR TB emerged globally in 2008, causing an estimated deaths [1]. More worrisome is the emergence of XDR TB, a nearly untreatable form of the disease with an estimated rate of 15% among the MDR strains [2]. In this review, the insights provided by molecular epidemiology with regard to global trends of transmission of MDR M. tuberculosis strains are presented and discussed in light of the actual expansion of MDR/XDR TB. Current Methods used for the Molecular Typing of MDR/XDR Strains of M. tuberculosis Restriction fragment length polymorphism (RFLP) analysis of IS6110 insertion sequence relies on the determination of the number of copies and location of insertion on the chromosome of the IS6110 element [3]. This technique is generally recognized as a reference standard for strain differentiation in molecular epidemiological studies, and has been widely used for the identification and investigation of outbreaks, the identification of laboratory cross-contamination, and distinction between re-infection and relapse [3]. However, the method has several disadvantages that seriously limit its use in routine practice: it has poor discriminatory power when applied to isolates with a low IS6110 copy number, it is labour-intensive, it requires significant amounts of high-qual- Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
2 CMI Sougakoff Molecular epidemiology of MDR M. tuberculosis 801 TABLE 1. Major phylogenetic lineages within the Mycobacterium tuberculosis complex (MTBC) strains adapted to humans MTBC species LSP-based lineage nomenclature Spoligotype-based families M. tuberculosis Indo-ic EAI M. tuberculosis East Asian Beijing M. tuberculosis East African Indian CAS M. tuberculosis Euro-American H, LAM, X, T, S, others M. africanum West African I AFRI2 M. africanum West African II AFRI1 AFRI, M. africanum; CAS, Central Asian; EAI, East African Indian; H, Haarlem; LAM, Latin American Mediterranean; LSP, large sequence polymorphism. ity DNA, and it generates band patterns that are difficult to share between laboratories. Spoligotyping, which is based on polymorphisms in the clustered regularly interspaced short palindromic repeats (CRISPRs), can be used for both epidemiology and evolutionary analysis of M. tuberculosis [4]. Technically, the method is based on the amplification and detection of the presence or absence of non-repetitive sequences called spacers found between direct repeat elements in the CRISPR region [5]. Because it is based on PCR amplification, spoligotyping can be performed with very small quantities of DNA, so the method does not require the handling of large amounts of resistant isolates. Over the years, the signatures given by the 43 spacer-spoligotyping patterns have been used to define strain families and create a very useful nomenclature with which to describe the circulating genotypes of tubercle bacilli worldwide (Table 1) [6]. As compared with the other molecular methods, the main limitation of spoligotyping is its inferior discriminatory power, especially in some lineages such as the Beijing strains, which nearly all share a single spoligotype. Variable numbers of tandem repeats (VNTR) analysis is a powerful method that can provide adequate discrimination of M. tuberculosis strains, in terms of both identification of genetic lineages and estimation of M. tuberculosis transmission [7]. The method, which is PCR-based, relies on the analysis of tandem repeats present in 41 genetic elements (called mycobacterial interspersed repetitive units (MIRUs)) scattered throughout the M. tuberculosis genome, with a variable number of copies of the repeat unit in each locus. MIRU- VNTR analysis, which is a PCR-based approach, is relatively safe when applied to MDR strains, and generates numerical values that can easily be compared in interlaboratory studies. This method has other major advantages, such as its use for phylogenetic analysis supported by a dedicated website (MIRU-VNTRplus, available at and a discriminatory power that is generally regarded as being similar to that of IS6110-RFLP. Owing to its acceptable discriminatory power and the exchangeable format of the data generated by the method, MIRU-VNTR typing is considered to be the new reference standard for molecular epidemiological studies. Phylogeographical Analysis of MDR/XDR M. tuberculosis Strains An overall picture of the epidemiology of MDR TB in the world can be drawn from the multiple studies that have analysed, by applying genetic approaches such as IS6110-RFLP, spoligotyping, and MIRU-VNTR, the specific situations encountered in representative areas of the world. Such studies are summarized hereafter, with the goal of presenting the landscape of MDR/XDR TB diversity in the world. In China, the rate of MDR TB (8% in 2007) is significantly higher than the global average rate, and represents a major public health challenge [8]. In this country, and more generally on the Asian continent, the Beijing family is very common, with a prevalence that exceeds 50% in many countries (China, South Korea, Hong Kong, and Thailand) [9]. A very recent study based on the use of spoligotyping and MIRU- VNTR determined the transmission characteristics of M. tuberculosis isolates in a province of China where the Beijing family prevails [8]. Strikingly, 90% of the strains were found to have the Beijing family genotype, and, among these, 27% were MDR. The clustering rate among the MDR strains was rather low (10%), indicating that these strains are characterized by a significant level of genomic diversity. In Japan, the frequencies of MDR TB and XDR TB are approximately 1.9% and 0.5%, respectively [10]. The transmission dynamics of MDR TB and XDR TB were analysed by IS6110-RFLP, spoligotyping and MIRU-VNTR on a set of 38 MDR and 17 XDR isolates [10]. The genetic family that dominated was found to be Beijing (62%), followed by T (13%), Latin American Mediterranean (LAM) (5%), U (2%), East African Indian (EAI) (2%) and X (2%). Interestingly, the proportion of Beijing genotype did not differ significantly between the MDR non-xdr and the XDR strains, but 70% of the XDR strains were involved in clusters, indicating that the XDR TB cases in Japan are more likely to be associated with clustering than the non-xdr TB cases (38% of clustered strains among the non-xdr cases) [10]. One possible explanation that could account for the high clustering rate of XDR TB reported in this study is that new cases of XDR TB are more likely to be caused by transmission than by acquisition of multidrug resistance resulting from treatment failure.
3 802 Clinical Microbiology and Infection, Volume 17 Number 6, June 2011 CMI A very similar study was conducted in Taiwan by investigating, with spoligotyping and MIRU-VNTR, the transmission and predominant genotypes involved in MDR TB [11]. In this region, where the prevalence of MDR TB was 4% in , the Beijing family genotype was still found to be the predominant genotype among the MDR strains (48%), followed by the Haarlem (15%) and T1 (4%) genotypes. Approximately 62% of the strains were clustered into ten clusters, and the largest cluster belonged to the Beijing genotype, a point that confirms the significant role played by this lineage in the extensive transmission of MDR TB in Taiwan. India has one of the highest estimated rates of TB in the world, and accounts for 21% of all TB cases [12]. In this country, it is estimated that 1 3.4% of new patients are infected by an MDR M. tuberculosis strain [13]. An analysis of MDR isolates by spoligotyping indicated that the most prevalent strain family is represented by the Beijing lineage (41%), followed by the EAI (27%), Manu1 (20%) and Central Asian (CAS) (17%) lineages [14]. Thus, despite the fact that the proportion of Beijing strains remains quite low in India (predominant spoligotypes belong to the Central Asian Delhi family), it seems that there is an association between the Beijing lineage and MDR TB in this country [14,15]. The epidemiological situation that prevails in eastern Europe and in the Russian Federation and the former Soviet Union countries is exemplified by the paper published by Niemann et al. [16], who analysed the population structure of M. tuberculosis complex strains from the Republic of Georgia by 24-locus MIRU-VNTR and spoligotyping. In this country, the frequency of MDR strains can reach levels of up to 40% among previously treated patients. Strikingly, MDR TB seems to be mostly associated with the diffusion of the Beijing lineage (77% of the MDR isolates), thus confirming that Beijing strains represent a major factor driving the MDR TB epidemic in eastern Europe [16]. Regarding the Russian Federation, a recent study has applied molecular typing to a panel of 76 MDR M. tuberculosis strains circulating in Moscow; it showed that 48% of the strains were grouped into 12 clusters, ten of them including strains belonging to the Beijing family, which represented 78% of the MDR strains [17]. Interestingly, the level of clustered strains was especially high (40%) for Beijing strains in the group of patients who had not been treated previously, an observation that was interpreted as evidence for the active transmission of such strains [17]. It is interesting to note that, in spite of the geographical proximity of countries where the Beijing sublineages are highly prevalent, the phylogenetic distribution observed in Sweden is very different from that reported for Russia and the Baltic countries. According to Ghebremichael et al. [18], only 13% of the patients with MDR TB were found to have Beijing strains, and the majority of these patients came from Asia (75%). Thus, in spite of the geographical proximity of Russia and the Baltic states, there is no extensive spreading of Beijing strains from these regions within any of the Scandinavian countries (in Finland and Denmark, the incidence of Beijing strains remains very low) [18]. A study published in 2010 presented a spoligotype-based analysis of MDR M. tuberculosis isolates in circulation in Poland, which is representative of the population structure characteristic of a European country [19]. Globally, the MDR strains were characterized by high genotypic diversity and a high number of unique profiles. Nevertheless, four major lineages, i.e. the T, Haarlem, LAM and Beijing families, constituted more than 67% of the strains studied, showing the compactness at the phylogenetic level of the MDR M. tuberculosis population structure in Poland. The highest number of MDR strains belonged to the ill-defined T family (28%), followed by the Haarlem (17%) and LAM (13%) families, the Beijing genotype accounting only for 9% of the MDR strains [19]. The three major genotype families found in this study (Haarlem, LAM, and T) are dominant in many European countries, where they represent up to 60% of M. tuberculosis strains found in Italy, 70% of those found in Sweden, and 80% of those found in Portugal [19]. In Poland, the low proportion of Beijing MDR strains (9%) contrasts with the high proportion of TB cases attributable to this lineage in the countries of the former Soviet Union (approximately 30 50%). Nonetheless, the presence of the Beijing lineage exclusively in the MDR group suggests that the ongoing transmission of Beijing strains is a significant cause of MDR TB in Poland. Interestingly, most of these strains were isolated from non-migrant patients born in Poland, which suggests that active transmission of MDR Beijing strains within the autochthonous population occurs in parallel with the more commonly observed transmission from immigrants from Asia and eastern Europe. When compared to that in Poland, the population structure of the MDR isolates circulating in Portugal presents interesting characteristics. This country has the fourth highest TB incidence rate in the European Union, with high levels of MDR TB (primary rate, 1.5%; retreatment cases, 2.4%) [20]. A study based on MIRU-VNTR typing indicates that a large proportion (55%) of the MDR strains from the Lisbon area belong to a single family related to the LAM genotype (referred to as the Lisboa family in the Perdigao s report), which caused a large MDR TB outbreak in the Lisbon region at the beginning of the 1990s. More alarming is the fact that 53% of these strains were XDR TB isolates, which repre-
4 CMI Sougakoff Molecular epidemiology of MDR M. tuberculosis 803 sents the highest XDR TB rate ever reported [21]. Thus, the development of XDR TB observed in the Lisbon region probably results from the circulation in the community of Lisboa MDR strains for more than 10 years, which has permitted the progressive acquisition of resistance to secondline drugs [21]. Finally, the population structure of the MDR isolates circulating in France has been evaluated by applying spoligotyping and 24-locus MIRU-VNTR to a panel of 98 MDR strains collected by the French National Reference Centre (CNR MyRMA) during the period (Sougakoff W, Veziris N, Millot G, Bastian S, Jarlier V, unpublished data). The overall distribution of the lineages on a map according to the patients country of birth confirms the predominance of the Beijing family among the MDR strains obtained from patients born in central Europe, eastern Europe, and Asia (approximately 75% of the MDR strains in this group of patients) (Fig. 1). Regarding the group of patients born in Africa, one can note a greater diversity of lineages, with a majority of strains being assigned to the ill-defined T lineage (52%), and the remainder to the T1-Ghana, Haarlem, LAM, Cameroon, TUR and Beijing families (Fig. 1). The MDR strains obtained from the patients born in France (10% of the MDR TB cases) were also found to belong to different lineages (Beijing, Ghana, T, LAM, and S) (Fig. 1). The minimum spanning tree shown in Fig. 2 reveals the high genetic heterogeneity and the complexity of the population structure for the MDR strains, with 13 clusters of strains sharing identical MIRU codes and representing 41% of the tested isolates. Six of the 13 clusters were attached to the Beijing genotype family within a single clonal complex encompassing 19% of the MDR strains (clonal complex 1 in Fig. 2). It is noticeable that no apparent epidemiological link was found for a majority (67%) of the MDR strains found in the six Beijing clusters, emphasizing the diversity of the Beijing strains circulating in France. Conclusions and Projections for the Future Molecular fingerprinting methods have undoubtedly had a very significant impact on ascertainment of the phylogeny of the bacilli that account for the worldwide diffusion of MDR TB and XDR TB, and elucidatation of the route of transmission of MDR TB. The report published in 2010 by Brown et al. [22] clearly confirms the tendencies highlighted by the various reports presented in this review. First, there is a strong association between a patient s country of origin and the family of the MDR isolates: Beijing dominates in patients Greenland Canada Suomi Finland Iceland Sverige Sweden Nor Nor United Kingdom Poiska Poland and ykpaïha aine Kazakhstan POCCRN Russia Monga ia South Pacific United States México Venezuela Colombia Brasil Brazil Bolivia Chile Argentina North Atlantic Turkey Turkey Iraq Iran Afghanistan Algeria Pakistan Libya Egypt Saudi Arabia India Mauritania Mali Niger Chad Sudan Nigeria Eth opia South Atlantic Kenya Congo Tanzania gola Namibia Botswana South Africa Madagascar Indian China Thailand Indonesia S korea Japan Australia Papua New Guinea FIG. 1. Geographical distribution of the lineages of multidrug-resistant strains (n = 98) received in by the French National Reference Centre for mycobacteria (CNR MyRMA), according to the country of birth of the patients. The diameters of coloured circles are proportional to the numbers of strains belonging to a given lineage. The colour indicates the mycobacterial interspersed repetitive unit (MIRU)-24-defined lineage to which each strain is related: Beijing is red, T is dark blue, T1-Ghana is light green, Haarlem is green, LAM is dark green, Cameroon is yellow orange, TUR is blue, S is light blue, Dehli/CAS is green khaki, and undetermined types are pink and violet.
5 804 Clinical Microbiology and Infection, Volume 17 Number 6, June 2011 CMI studies is that the Beijing family could be strongly associated with multidrug resistance [22], and has spread globally in recent years, now representing a major factor driving the MDR TB epidemic in the world [16]. In this context, molecular epidemiology of MDR M. tuberculosis should progress to improve our capacity to detect chains of transmission and enhance TB control activities. Transparency Declaration The author does not have any conflict of interest to declare. References FIG. 2. Minimum spanning tree based on the diversity of the 24- locus mycobacterial interspersed repetitive unit (MIRU)-variable numbers of tandem repeats (VNTR) results for a representative sample of multidrug-resistant strains received at the French National Reference Centre (CNR MyRMA) ( ). The main clonal complexes (CCs) are indicated (a CC consists of strains that differ from each other by a single locus change): CC1, Beijing; CC2, probably Haarlem; CC3, T1-Ghana; CC4, T2 T3; CC5, S. Clusters are indicated by filled circles. The tree was drawn by using the MIRU- VNTRplus website. born in East Asia, whereas CAS, EAI and Beijing dominate in patients born on the Indian subcontinent [22]. In contrast, the strains grouped in the Euro-American superfamily (encompassing the LAM, Haarlem and T lineages) are infrequent in these regions, but are globally equally distributed in all other regions of the world. The other important and worrying conclusion that can be drawn from genotyping 1. Prasad R. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions. Indian J Tuberc 2010; 57: Shah NS, Wright A, Bai GH et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2007; 13: McEvoy CR, Falmer AA, Gey van Pittius NC, Victor TC, van Helden PD, Warren RM. The role of IS6110 in the evolution of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2007; 87: van Embden JD, van Gorkom T, Kremer K, Jansen R, van Der Zeijst BA, Schouls LM. Genetic variation and evolutionary origin of the direct repeat locus of Mycobacterium tuberculosis complex bacteria. J Bacteriol 2000; 182: Kato-Maeda M, Metcalfe JZ, Flores L. Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol 2011; 6: Brudey K, Driscoll JR, Rigouts L et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6: Supply P, Mazars E, Lesjean S, Vincent V, Gicquel B, Locht C. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 2000; 36: Wang J, Liu Y, Zhang CL et al. Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China. J Clin Microbiol 2011; 49: Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: Murase Y, Maeda S, Yamada H et al. Clonal expansion of multidrugresistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis 2010; 16: Hsu AH, Lin CB, Lee YS et al. Molecular epidemiology of multidrugresistant Mycobacterium tuberculosis in Eastern Taiwan. Int J Tuberc Lung Dis 2010; 14: Stavrum R, Myneedu VP, Arora VK, Ahmed N, Grewal HM. In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi predominance of drug resistant isolates of the modern (TbD1) type. PLoS ONE 2009; 4: e Kant S, Maurya AK, Kushwaha RA, Nag VL, Prasad R. Multi-drug resistant tuberculosis: an iatrogenic problem. Biosci Trends 2010; 4: Chatterjee A, D Souza D, Vira T et al. Strains of Mycobacterium tuberculosis from western Maharashtra, India, exhibit a high degree of diversity and strain-specific associations with drug resistance,
6 CMI Sougakoff Molecular epidemiology of MDR M. tuberculosis 805 cavitary disease, and treatment failure. J Clin Microbiol 2010; 48: Purwar S, Chaudhari S, Katoch VM et al. Determination of drug susceptibility patterns and genotypes of Mycobacterium tuberculosis isolates from Kanpur district, North India. Infect Genet Evol 2011; 11: Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang YW. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J Clin Microbiol 2010; 48: Afanas ev MV, Ikryannikova LN, Il ina EN et al. Molecular typing of Mycobacterium tuberculosis circulated in Moscow, Russian Federation. Eur J Clin Microbiol Infect Dis 2011; 30: Ghebremichael S, Groenheit R, Pennhag A et al. Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden. PLoS ONE 2010; 5: e Jagielski T, Augustynowicz-Kopec E, Zozio T, Rastogi N, Zwolska Z. Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland. J Clin Microbiol 2010; 48: Perdigao J, Macedo R, Joao I, Fernandes E, Brum L, Portugal I. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. Microb Drug Resist 2008; 14: Perdigao J, Macedo R, Malaquias A, Ferreira A, Brum L, Portugal I. Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. J Antimicrob Chemother 2010; 65: Brown T, Nikolayevskyy V, Velji P, Drobniewski F. Associations between Mycobacterium tuberculosis strains and phenotypes. Emerg Infect Dis 2010; 16:
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
More informationHow Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008
How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 Today s Outline 1) Global spread of Mtb Comparative genomics Phylogeny 2) Transmission of drug-resistant Mtb Fitness assays Molecular epidemiology
More informationMolecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis
Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management
More informationTransmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos
Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious
More informationA tale of two settings: the role of the Beijing genotype in the epidemiology of MDR-TB.
ERJ Express. Published on September 13, 2013 as doi: 10.1183/09031936.00140513 A tale of two settings: the role of the Beijing genotype in the epidemiology of MDR-TB. Helen R. Stagg a,b,c, *, Ted Cohen
More informationGlobal Measles and Rubella Update November 2018
Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationGlobal Measles and Rubella Update. April 2018
Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationDrug-resistant Tuberculosis
page 1/15 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Level 2 - Details on Drug-resistant Tuberculosis 1. What is tuberculosis and why is it
More informationMultidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area
Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)
More informationMultidrug-resistant Tuberculosis - World, Europe, Switzerland
Multidrug-resistant Tuberculosis - World, Europe, Switzerland Magglingen March 23, 2017 peter.helbling@bag.admin.ch Topics Definitions Epidemiology of TB and MDR-TB worldwide Treatment outcome results
More informationGlobal epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos
Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationCurrent State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2
Current State of Global HIV Care Continua Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 1) International Association of Providers of AIDS Care
More informationGlobal Measles and Rubella Update October 2018
Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug
More informationWild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
More informationAnnex 2 A. Regional profile: West Africa
Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262
More informationInternational Tuberculosis Research Center, Changwon, Republic of Korea
EVALUATION OF MYCOBACTERIAL INTERSPERSED REPETITIVE UNIT-VARIABLE NUMBER TANDEM REPEAT TYPING TO DISCRIMINATE MYCOBACTERIUM TUBERCULOSIS STRAINS FROM MYANMAR Phyu Win Ei 1,2, Wah Wah Aung 1, Wint Wint
More informationGlobal EHS Resource Center
Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research
More informationXDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
More informationDrug-resistant Tuberculosis
page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of
More informationTB, BCG and other things. Chris Conlon Infectious Diseases Oxford
TB, BCG and other things Chris Conlon Infectious Diseases Oxford Epidemiology Latent TB IGRA BCG >50/100000
More informationDrug resistance TB in People Living with HIV: research questions and priorities.
Drug resistance TB in People Living with HIV: research questions and priorities. Haileyesus Getahun, MD, PhD. Stop TB Department World Health Organisation Geneva, Switzerland Outline of presentation Definition
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationGenotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns,
ORIGINAL ARTICLE BACTERIOLOGY Genotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns, 2008 2011 P. W. Smit 1,2, M. Haanper a 2, P. Rantala 2,
More informationMain developments in past 24 hours
ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance
More informationOUT-TB Web. Ontario Universal Typing of Tuberculosis: Surveillance and Communication System
OUT-TB Web Ontario Universal Typing of Tuberculosis: Surveillance and Communication System Dr. Frances Jamieson, Ontario Public Health Laboratories November 30 th, 2009 Tuberculosis : A Global Problem
More informationWhat can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
More informationMIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece
Therapeutic Advances in Respiratory Disease Original Research MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece Nikoletta Rovina, Simona Karabela, Pantelis Constantoulakis, Vassiliki Michou,
More informationRecommended composition of influenza virus vaccines for use in the 2007 influenza season
Recommended composition of influenza virus vaccines for use in the 2007 influenza season September 2006 This recommendation relates to the composition of vaccines for the forthcoming winter in the southern
More informationA study on pre-xdr & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
Indian J Med Res 143, March 2016, pp 341-347 DOI:10.4103/0971-5916.182625 A study on pre-xdr & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationHIV and Harm Reduction in Prisons
HIV and Harm Reduction in Prisons School of Public Health and Community Medicine Professor Kate Dolan Program of International Research and Training National Drug and Alcohol Research Centre UNSW, Sydney,
More information3.1 PHASE 2 OF THE GLOBAL PROJECT
RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided
More informationTHE CARE WE PROMISE FACTS AND FIGURES 2017
THE CARE WE PROMISE FACTS AND FIGURES 2017 2 SOS CHILDREN S VILLAGES INTERNATIONAL WHERE WE WORK Facts and Figures 2017 205 58 79 families and transit 31 Foster homes 162 8 3 173 214 2 115 159 136 148
More informationXDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine
XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution
More informationGuidance for Travelers on Temporary Work Assignment Abroad
infected person to immediately seek medical care but, prior to arrival, notify their healthcare provider that they may have been exposed to AI. For more information about avian influenza, see www.cdc.gov/flu/avian/facts.htm,
More informationA ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia ( )
A ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011) Naira Dekhil 1, Besma Mhenni 1, Raja Haltiti 2, and Helmi Mardassi 1 (speaker)
More informationMycobacterium tuberculosis and Molecular Epidemiology: An Overview
Journal of Microbiology Research 2014, 4(6A): 25-31 DOI: 10.5923/s.microbiology.201401.04 Mycobacterium tuberculosis and Molecular Epidemiology: An Overview Asho Ali Department of Biology, King Abdul Aziz
More informationHigh Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India
BRIEF REPORT High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India Deepak Almeida, 1 Camilla Rodrigues, 2 Tester
More informationGOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights
GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.
More informationTransmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012
Research articles Transmission of multidrug-resistant in a low-incidence setting, Switzerland, 2006 to 2012 A Somoskovi (asomoskoevi@imm.uzh.ch) 1, P Helbling 2, V Deggim 1, R Hömke 1, C Ritter 1, E C
More informationMIRU-VNTR.. (HGI) HunterGaston Discriminatory Index MIRU-VNTR :
- ( ) MIRU- *. :. 12 MIRU- 15 MIRU-. MIRU-. (HGI) HunterGaston Discriminatory Index.( ) : MIRU- QUB11b.(HGI=) QUB26 (HGI /) QUB26. MIRU16. MIRU26 MIRU23 MIRU27 MIRU39 Mtub21.(HGI
More informationTuberculosis Genotyping in British Columbia
Tuberculosis Genotyping in British Columbia 10-year Retrospective Study Report Prepared by: Jennifer L. Guthrie, PhD Candidate Email: jennifer.guthrie@alumni.ubc.ca School of Population and Public Health
More informationRecommended composition of influenza virus vaccines for use in the influenza season
Recommended composition of influenza virus vaccines for use in the 2006 2007 influenza season This recommendation relates to the composition of vaccines for the forthcoming influenza season in the northern
More informationUpdate on Progress and Challenges in Achieving Measles and Rubella Targets
Update on Progress and Challenges in Achieving Measles and Rubella Targets SAGE Meeting 6 November 2013 P. Strebel, WHO/IVB/EPI Overview Global progress Regional updates Summary 2 Measles and Rubella Targets
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationGlobal TB Burden, 2016 estimates
TUBERCULOSIS EPIDEMIOLOGY LOCAL, STATE, NATIONAL, GLOBAL Office of Communicable Disease Epidemiology Global TB Burden, 216 estimates Total TB Estimated number of TB cases 1.4 million 14 per 1, Estimated
More informationMain global and regional trends
I N T R O D U C T I O N Main global and regional trends Promising developments have been seen in recent years in global efforts to address the AS epidemic, including increased access to effective treatment
More informationWorld Connections Committee (WCC) Report
World Connections Committee (WCC) Report 06 Co-Dependents Anonymous Service Conference Countries Where CoDA Exists This report reflects the World Connections Committee (WCC) support of the growth and development
More information4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB
Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people
More informationCotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13
Cotton Trade Net Exporters Africa Argentina Australia India Other Former Soviet Union Other Latin America Other Middle East Pakistan Turkey United States Uzbekistan Total Net Exports 5.01 5.62 5.62 5.66
More informationEmergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
CHEST Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Original Research Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran Ali Akbar Velayati,
More informationScott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of
More informationExamining the sublineage structure of Mycobacterium tuberculosis complex strains with multiple-biomarker tensors
2010 IEEE International Conference on Bioinformatics and Biomedicine Examining the sublineage structure of Mycobacterium tuberculosis complex strains with multiple-biomarker tensors Cagri Ozcaglar 1, Amina
More informationWest Nile Disease. World situation and impact on public health
West Nile Disease World situation and impact on public health Contents Global view on WNV The Public Health consequences: the case of USA WNV circulation in Europe and Mediterranean Basin West Nile Disease
More informationEstimates for the mutation rates of spoligotypes and VNTR types of Mycobacterium tuberculosis
Estimates for the mutation rates of spoligotypes and VNTR types of Mycobacterium tuberculosis Josephine F. Reyes and Mark M. Tanaka November 30, 2009 1/21 Understanding diversity in bacterial pathogens
More informationSeizures of ATS (excluding ecstasy ), 2010
Seizures of ATS (excluding ecstasy ), 2010 (countries and territories reporting seizures* of more than 10 kg) 9 5.1 8.7 12.9 Ghana Armenia 0.7 9.9 1 2.1 Syrian Arab Republic Korea (Republic of) Iraq Islamic
More informationFilipa Matos, Mónica V. Cunha*, Ana Canto, Teresa Albuquerque, Alice Amado, and. INRB, I.P./LNIV- Laboratório Nacional de Investigação Veterinária
JCM Accepts, published online ahead of print on 15 September 2010 J. Clin. Microbiol. doi:10.1128/jcm.01762-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationThe United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America
The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations
More informationGlobal Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
More informationInfluenza Update N 176
Update N 176 04 January 2013 Summary Reporting of influenza activity has been irregular in the past two weeks due to the holiday season in many countries. As a result, overall virus detections have dropped
More informationSGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:
SGCEP SCIE 1121 Environmental Science Spring 2012 Section 20531 Steve Thompson: steventhompson@sgc.edu http://www.bioinfo4u.net/ 1 First, a brief diversion... Into... how to do better on the next exam,
More informationEU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017
EU Market Situation for Poultry Committee for the Common Organisation of the Agricultural Markets 2 April 217 -9.% -11.% -5.% -.1% -.7% -2.2% 3.% 1.7% 1.2%.8%.6%.%.%.% 7.9% 7.% 6.4% 6.2% 6.% 5.5% 5.3%
More informationInfluenza Update N 157
Influenza Update N 157 13 April 2012 Summary In most areas of the northern hemisphere temperate regions, influenza activity appears to have peaked and is declining. In North America, influenza indicators
More informationDrug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )
1 / 11 Region/Subregion/ Country Africa Eastern Africa Kenya Madagascar Mauritius Uganda United Republic of Tanzania Northern Africa Algeria Egypt Libya Morocco Sudan Southern Africa Botswana Burkina Faso
More informationDrug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye
Director of Health Information World Health Organization Geneva 1 1. Why TB patients are treated with drugs 2 Natural history and control of TB Fast 5/1 Slow 5/1 Uninfected Latent Active 1 1 infection/case
More informationFoot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report
Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report October 2013 I N F O R M A T I O N S O U R C E S U S E D: Databases: OIE WAHID World Animal Health
More informationChapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United
More informationUndetectable = Untransmittable. Mariah Wilberg Communications Specialist
Undetectable = Untransmittable Mariah Wilberg Communications Specialist Undetectable=Untransmittable PLWH who get and stay undetectable have effectively no risk of transmitting HIV to their sex partners
More informationEnriched RWE study in the Nordics a case study
Enriched RWE study in the Nordics a case study RWD conf. Helsinki, November 28, 2018 Susanne Kihlblom, MSc Pharm., Diplom.Clin.Trials Copyright 2017 IQVIA. All rights reserved. IQVIA 2017. All rights reserved.
More informationMolecular epidemiology of Mycobacterium tuberculosis in East Lancashire 2001e2009
1 HPA Regional Centre for Mycobacteriology, Newcastle General Hospital, Newcastle upon Tyne, UK 2 Department of Microbiology, Royal Blackburn Hospital, Blackburn, Lancashire, UK 3 Department of Respiratory
More informationAvailable Hepatitis Information: how can this be used to convince decision makers and potential funders
Available Hepatitis Information: how can this be used to convince decision makers and potential funders H. Razavi June 6, 2015 Viral Hepatitis Prevention Board Meeting, London, UK 56 June 2015 It s not
More informationVNTR . VNTR. VNTR. (Original Article) PCR-RFLP ( ETR-B, ETR-C, ETR-D, ETR-E, ETR-F : 7 .VNTR : : (Atypical Mycobacteria)
90 11 3 (Original Article) 4 3 2 1 1. 2. 3. 4. (Non- Tuberculosis Mycobacterium, NTM) :.. (Variable Number Tandem Repeat, VNTR). VNTR ) 48 : PCR-RFLP ( MPTR-A, ETR-A, ETR-B, ETR-C, ETR-D, ETR-E, ETR-F
More informationMolecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research
Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research " Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market
More informationREPORT ON AVIAN INFLUENZA (AI) SURVEILLANCE MONITORING FOR THE SURVEILLANCE PERIOD: July 2017 to December 2017 (2H 2017)
REPORT ON AVIAN INFLUENZA (AI) SURVEILLANCE MONITORING FOR THE SURVEILLANCE PERIOD: July 2017 to December 2017 (2H 2017) CONTENTS Page 1 OVERVIEW 2 2 RESULTS OF AI SURVEILLANCE MONITORING: 2H 2017 2 2.1
More informationGLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA
GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA Dr Gounalan Pavade OIE Regional Expert Group Meeting for the Control of Avian Influenza in Asia Sapporo, Japan 3-5 October 2017 1 Avian influenza Outbreaks
More informationPATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA
PATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA DN Magana-Arachchi 1, AJ Perera 1, V Senaratne 2 and NV Chandrasekharan
More informationAnnual surveillance report 2015
Annual surveillance report 215 Acknowledgements The Public Health Agency Northern Ireland gratefully acknowledges all those who contributed to this report, including; physicians, nurses, microbiologists,
More informationGLOBAL FMD SITUATION DURING 2001/2002
APPENDIX 2 GLOBAL FMD SITUATION DURING 2001/2002 Report of the FAO/OIE World Reference Laboratory for FMD, Institute for Animal Health, Ash Road, Pirbright, Woking, Surrey GU24 ONF, United Kingdom Tables
More informationPandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva
Pandemic H1N1 2010 Dr. Maria Neira Global Influenza Programme WHO, Geneva WHO Role during pandemic (H1N1) 2009 Under the International Health Regulations (2005) Detect event (notification by Member States
More informationTerms and Conditions. VISA Global Customer Assistance Services
Terms and Conditions VISA Global Customer Assistance Services Visa Global Customer Assistance Services (VGCAS) 1 The Visa Global Customer Assistance Services are co-ordinated by the Global Assistance Centre
More informationAssociation of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease
ORIGINAL ARTICLE 10.1111/j.1469-0691.2009.02712.x Association of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease N. Lari 1, L.
More informationCountry-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank
Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank Country CAPEXIL Description HS Code Value 2010-2011 Quantity 2010-2011
More informationGenetic diversity of Mycobacterium tuberculosis isolates from Beijing, China assessed by Spoligotyping, LSPs and VNTR profiles
Lu et al. BMC Infectious Diseases 2012, 12:372 RESEARCH ARTICLE Open Access Genetic diversity of Mycobacterium tuberculosis isolates from Beijing, China assessed by Spoligotyping, LSPs and VNTR profiles
More informationLaura Rindi*, Chiara Medici, Nicola Bimbi, Andrea Buzzigoli, Nicoletta Lari, Carlo Garzelli. Abstract. Introduction
Genomic Variability of Mycobacterium tuberculosis Strains of the Euro-American Lineage Based on Large Sequence Deletions and 15-Locus MIRU-VNTR Polymorphism Laura Rindi*, Chiara Medici, Nicola Bimbi, Andrea
More informationOIE Situation Report for Avian Influenza
OIE Situation Report for Avian Influenza Latest update: 08/05/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening
More informationAvian Influenza/Newcastle Disease Virus Subcommittee
Avian Influenza/Newcastle Disease Virus Subcommittee David L. Suarez D.V.M., Ph.D. Patti Miller D.V.M., Ph.D. Claudio Afonso Ph.D. Southeast Poultry Research Laboratory United States National Poultry Research
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More informationHIBA ABDALRAHIM Capsca Focal Point Public Health Authority
HIBA ABDALRAHIM Capsca Focal Point Public Health Authority Introduction Definition Symptom Transmission Global situation Local situation Control Content Introduction Yellow fever (YF) is a mosquito-borne
More informationSubstance Abuse and Tuberculosis Springfield, IL April 27, 2011
5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,
More informationOptimal Combination of VNTR Typing for Discrimination of Isolated Mycobacterium tuberculosis in Korea
ORIGINAL ARTICLE http://dx.doi.org/10.4046/trd.2014.76.2.59 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;76:59-65 Optimal Combination of VNTR Typing for Discrimination of Isolated Mycobacterium
More informationTuberculosis Elimination, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01711.x Association of specific mutations in katg, rpob, rpsl and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationAnnual Tuberculosis Report Oregon 2007
Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page
More informationTuberculosis Disparity Between US-born African-Americans and Caucasians in Houston:
Tuberculosis Disparity Between US-born African-Americans and Caucasians in Houston: A population-based study Jose A. Serpa 1, M.D.; Larry D. Teeter 2, Ph.D., James M. Musser 2, M.D., Ph.D. and Edward A.
More information1. Introduction. Correspondence should be addressed to Qun Sun;
BioMed Research International Volume, Article ID, pages http://dx.doi.org/.// Research Article Suitability of IS-RFLP and MIRU-VNTR for Differentiating Spoligotyped Drug-Resistant Mycobacterium tuberculosis
More informationUndiscovered progress in. in maternal mortality.
CHAPTER 1 Undiscovered progress in maternal mortality During the early 1980s, a half-million women died every year during pregnancy, childbirth, or the postpartum period a stunning figure in a world that
More information